These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 34572727)
1. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer. Heidrich I; Abdalla TSA; Reeh M; Pantel K Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572727 [TBL] [Abstract][Full Text] [Related]
3. Circulating biomarkers for early detection and clinical management of colorectal cancer. Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073 [TBL] [Abstract][Full Text] [Related]
4. Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer. Hench IB; Hench J; Tolnay M Front Med (Lausanne); 2018; 5():9. PubMed ID: 29441349 [TBL] [Abstract][Full Text] [Related]
5. Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies. Tellez-Gabriel M; Knutsen E; Perander M Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322643 [TBL] [Abstract][Full Text] [Related]
6. Role of liquid biopsies in colorectal cancer. Wills B; Gorse E; Lee V Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335 [TBL] [Abstract][Full Text] [Related]
7. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics]. Haupts A; Roth W; Hartmann N Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045 [TBL] [Abstract][Full Text] [Related]
8. Detection and clinical significance of circulating tumor cells in colorectal cancer. Jiang M; Jin S; Han J; Li T; Shi J; Zhong Q; Li W; Tang W; Huang Q; Zong H Biomark Res; 2021 Nov; 9(1):85. PubMed ID: 34798902 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer. Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; López-López R; Muinelo-Romay L; Diaz-Lagares A Front Cell Dev Biol; 2021; 9():622459. PubMed ID: 33614651 [TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time? Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267 [TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons. Tan CR; Zhou L; El-Deiry WS Curr Colorectal Cancer Rep; 2016 Jun; 12(3):151-161. PubMed ID: 27516729 [TBL] [Abstract][Full Text] [Related]
12. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review. Vymetalkova V; Cervena K; Bartu L; Vodicka P Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373199 [TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in breast cancer: A comprehensive review. Alimirzaie S; Bagherzadeh M; Akbari MR Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931 [TBL] [Abstract][Full Text] [Related]
14. Early Detection, Precision Treatment, Recurrence Monitoring: Liquid Biopsy Transforms Colorectal Cancer Therapy. Raval H; Bhattacharya S Curr Cancer Drug Targets; 2024 Apr; ():. PubMed ID: 38623975 [TBL] [Abstract][Full Text] [Related]
15. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios. Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724 [TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer. Jia S; Zhang R; Li Z; Li J Oncotarget; 2017 Aug; 8(33):55632-55645. PubMed ID: 28903450 [TBL] [Abstract][Full Text] [Related]
17. Perspectives of the Application of Liquid Biopsy in Colorectal Cancer. Ding Y; Li W; Wang K; Xu C; Hao M; Ding L Biomed Res Int; 2020; 2020():6843180. PubMed ID: 32258135 [TBL] [Abstract][Full Text] [Related]
18. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer. Zhang X; Ju S; Wang X; Cong H Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187 [TBL] [Abstract][Full Text] [Related]
19. Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management. Hallermayr A; Steinke-Lange V; Vogelsang H; Rentsch M; de Wit M; Haberl C; Holinski-Feder E; Pickl JMA Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159118 [TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Liquid Biopsy in Gastric Cancer. Lengyel CG; Hussain S; Trapani D; El Bairi K; Altuna SC; Seeber A; Odhiambo A; Habeeb BS; Seid F J Clin Med; 2021 May; 10(10):. PubMed ID: 34068319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]